Cincinnati, Ohio
Phase 1 colorectal cancer trials in Cincinnati, OH
12 Phase 1 colorectal cancer studies are recruiting participants at sites in Cincinnati as of November 17, 2026, according to ClinicalTrials.gov. Colorectal Phase 1 Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Cincinnati at a glance
- 12 studies are recruiting at a site in Cincinnati.
- By phase: Phase 1 (6), Phase 1/2 (6).
- By sponsor: industry (9), government (2), university, hospital or other (1).
- Most recent update to one of these records: October 28, 2026.
Studies recruiting in Cincinnati
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- University of Cincinnati Cancer Center-UC Medical Center
- Registry record
- NCT05803382 · updated
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Artios Pharma Ltd
- Study site
- Oncology Hematology Care Primary
- Registry record
- NCT04657068 · updated
Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- University of Cincinnati Cancer Center-UC Medical Center
- Registry record
- NCT06654037 · updated
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Dispatch Biotherapeutics
- Study site
- University of Cincinnati Cancer Center
- Registry record
- NCT07544589 · updated
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- University of Cincinnati Medical Center
- Registry record
- NCT06445062 · updated
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Phase 1
- Ages 12 to 85
- All sexes
- Sponsor
- Inhibrx Biosciences, Inc
- Study site
- Cincinnati Children's Hospital Medical Center
- Registry record
- NCT03715933 · updated
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Phase 1/2
- From 12 months, up to 30 years
- All sexes
- Sponsor
- Children's Oncology Group
- Study site
- Cincinnati Children's Hospital Medical Center
- Registry record
- NCT04851119 · updated
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Xencor, Inc.
- Study site
- Xencor Investigative Site
- Registry record
- NCT05433142 · updated
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Study site
- University of Cincinnati Cancer Center
- Registry record
- NCT03947385 · updated
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- The Christ Hospital
- Registry record
- NCT06040541 · updated
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- Christ Hospital Cancer Center
- Registry record
- NCT05379985 · updated
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
- Phase 1/2
- Ages 15 and older
- All sexes
- Sponsor
- Lantheus Medical Imaging
- Study site
- Cincinnati Children's Hospital Medical Center
- Registry record
- NCT06298916 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Cincinnati, OH on ClinicalTrials.gov.
Ask about studies near Cincinnati
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Ohio
All Ohio locations
43 studies recruiting across 6 cities.
Cleveland
20 studies recruiting.
Columbus
14 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Colorectal Phase 1 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections